ArticleInternational journal of molecular sciences2023

Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype.

Eric W J Gates et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.